OrbiMed’s BlossomHill Therapeutics BLSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$50.6M Buy
+2,714,279
New +$53.9M 0.92% 31

Other funds holding BLSM

OrbiMed's BLSM Position: Q3 2026 in Review

OrbiMed opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 2,714,279 shares worth $50.6M. The stake represents 0.92% of the portfolio and ranks #31 among its holdings.

39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.

  • OrbiMed held 2,714,279 shares of BlossomHill Therapeutics worth $50.6M as of Q3 2026.
  • BlossomHill Therapeutics was a new OrbiMed position in Q3 2026.
  • BlossomHill Therapeutics made up 0.92% of OrbiMed's portfolio in Q3 2026, its #31 holding.
  • 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.

Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.